PapersFlow Research Brief
Biological Activity of Diterpenoids and Biflavonoids
Research Guide
What is Biological Activity of Diterpenoids and Biflavonoids?
Biological Activity of Diterpenoids and Biflavonoids refers to the pharmacological effects, including antitumor, antiviral, anti-inflammatory, and cytotoxic actions, exhibited by these classes of natural products derived from plants.
This field encompasses 29,139 papers on the biological activity, synthesis, and pharmacology of diterpenoids and biflavonoids. Research covers antitumor activity, antiviral evaluation, anti-inflammatory action, cytotoxicity, and total synthesis of these compounds. Key works highlight plants as sources of anti-cancer agents and plant secondary metabolites as successful anticancer agents in clinical trials.
Topic Hierarchy
Research Sub-Topics
Antitumor Activity of Diterpenoids
Researchers evaluate cytotoxicity, apoptosis induction, and mechanism-of-action of diterpenoids like taxol analogs against cancer cell lines, including in vivo xenograft models. Studies cover structure-activity relationships and clinical translation potential.
Antiviral Evaluation of Biflavonoids
This sub-topic assesses inhibitory effects of biflavonoids on viruses like HIV, dengue, and influenza through in vitro assays, binding studies, and viral replication models. Research identifies active compounds from plant sources and optimizes derivatives.
Anti-inflammatory Action of Diterpenoids
Studies investigate modulation of NF-κB pathways, cytokine suppression, and COX inhibition by diterpenoids in inflammation models like LPS-induced macrophages and arthritis. Focus includes natural vs. semisynthetic variants.
Total Synthesis of Complex Diterpenoids
Synthetic chemists develop stereoselective routes to bioactive diterpenoids such as ingenol or kaurene skeletons using cascade reactions and biocatalysis. Emphasis is on scalability, atom economy, and analog generation for SAR studies.
Cytotoxicity Mechanisms of Biflavonoids
Researchers elucidate ROS generation, mitochondrial disruption, and topoisomerase inhibition underlying biflavonoid cytotoxicity in tumor cells via omics profiling and knockout models. Comparative toxicology in normal cells is also examined.
Why It Matters
Diterpenoids and biflavonoids contribute to drug discovery through their antitumor and cytotoxic activities, with plants serving as sources for 40% of FDA-approved anticancer molecules as noted in Seca and Pinto (2018). "Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application" (2018) details therapeutic applications in cancer treatment, a leading cause of mortality. Cragg and Newman (2005) in "Plants as a source of anti-cancer agents" identify natural products like these in clinical successes, supporting their role in oncology and related fields such as anti-inflammatory pharmacology.
Reading Guide
Where to Start
"Plants as a source of anti-cancer agents" by Cragg and Newman (2005) provides an accessible entry point, as it reviews plants as sources of agents relevant to diterpenoid antitumor activity with 2012 citations.
Key Papers Explained
Cragg and Newman (2005) in "Plants as a source of anti-cancer agents" establishes natural products as anticancer sources, which Seca and Pinto (2018) in "Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application" builds upon by detailing clinical trial successes including 40% FDA natural approvals. Harborne (1984) "Phytochemical Methods" supports analysis methods used in these studies, while Cooper-Driver and Harborne (1974) "Phytochemical Methods" offers foundational techniques connecting to Mahato and Kundu (1994) NMR compilation for structural insights.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Current research emphasizes pharmacology of diterpenoids in cancer biochemical pathways and biflavonoids in anti-inflammatory signaling, with no recent preprints available. Focus persists on cytotoxicity and total synthesis amid 29,139 works.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Plants as a source of anti-cancer agents | 2005 | Journal of Ethnopharma... | 2.0K | ✓ |
| 2 | Phytochemical Methods | 1974 | Kew Bulletin | 1.5K | ✕ |
| 3 | 13C NMR Spectra of pentacyclic triterpenoids—a compilation and... | 1994 | Phytochemistry | 1.3K | ✕ |
| 4 | Phytochemical Methods | 1984 | — | 1.2K | ✕ |
| 5 | In vitro antiproliferative, apoptotic and antioxidant activiti... | 2005 | The Journal of Nutriti... | 1.1K | ✕ |
| 6 | Antioxidant, antimicrobial, antiulcer and analgesic activities... | 2003 | Journal of Ethnopharma... | 839 | ✕ |
| 7 | Medicinal properties of mangosteen (Garcinia mangostana) | 2008 | Food and Chemical Toxi... | 742 | ✕ |
| 8 | Medicinal natural products. A biosynthetic approach | 2002 | Journal of Ethnopharma... | 669 | ✕ |
| 9 | Plant Secondary Metabolites as Anticancer Agents: Successes in... | 2018 | International Journal ... | 651 | ✓ |
| 10 | Antioxidant and free radical scavenging activity of Spondias p... | 2008 | BMC Complementary and ... | 621 | ✓ |
Frequently Asked Questions
What antitumor activities are associated with diterpenoids and biflavonoids?
Diterpenoids and biflavonoids exhibit antitumor activity through mechanisms targeting uncontrolled cell division in cancer. Seca and Pinto (2018) report that plant secondary metabolites, including these compounds, have succeeded in clinical trials for cancer therapy. FDA data indicate 40% of approved anticancer molecules are natural products.
How do natural products like diterpenoids contribute to anti-cancer agents?
Plants provide anti-cancer agents via diterpenoids and biflavonoids with cytotoxic effects. Cragg and Newman (2005) in "Plants as a source of anti-cancer agents" document their role in pharmacology. These compounds support synthesis and evaluation for antitumor applications.
What methods are used to study phytochemicals in diterpenoids and biflavonoids?
Phytochemical methods analyze the isolation and identification of diterpenoids and biflavonoids. Harborne (1984) in "Phytochemical Methods" outlines techniques for their characterization. These approaches aid in assessing biological activities like anti-inflammatory action.
Which plant secondary metabolites show clinical success as anticancer agents?
Diterpenoids and biflavonoids qualify as plant secondary metabolites with anticancer potential in clinical trials. Seca and Pinto (2018) confirm successes in therapeutic application against cancer. Their cytotoxicity targets multistage cell division processes.
What is the scope of biological activities for these natural products?
Biological activities include antitumor, antiviral, anti-inflammatory, and cytotoxicity for diterpenoids and biflavonoids. The field spans 29,139 papers on their pharmacology and synthesis. Evaluations focus on natural products from plants.
Open Research Questions
- ? How can total synthesis of specific diterpenoids enhance their antiviral evaluation beyond natural extraction?
- ? What structural features of biflavonoids optimize anti-inflammatory action in immune disorders?
- ? Which combinations of diterpenoids with other polyphenols maximize cytotoxicity in renal and related cancers?
- ? How do diterpenoids interact with Wnt/β-catenin signaling to inhibit cancer development?
- ? What role do biflavonoids play in enzyme inhibition for inflammasome-related disorders?
Recent Trends
The field maintains 29,139 papers with no specified 5-year growth rate, sustaining focus on antitumor activity and pharmacology.
Seca and Pinto marks a recent high-cited work (651 citations) on clinical successes of plant metabolites like diterpenoids, absent new preprints or news in the last 12 months.
2018Research Biological Activity of Diterpenoids and Biflavonoids with AI
PapersFlow provides specialized AI tools for Biochemistry, Genetics and Molecular Biology researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Biological Activity of Diterpenoids and Biflavonoids with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Biochemistry, Genetics and Molecular Biology researchers